Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > is it or isn't it?
View:
Post by itntdf on Jan 11, 2023 8:57pm

is it or isn't it?

the license, development, supply and distribution agreement signed nov. 16, 2017, took great pains to say the following:

27.
NATURE OF THIS AGREEMENT
27.1
The Parties are independent contractors and none of the provisions of this Agreement shall be deemed to constitute a partnership or joint venture between the Parties. Neither Party shall have any authority to bind the other in any way.

 
Yet, in the January, 2023 Investor Presentation, oncy states:
 
Successful partnership with Adlai Nortye
China, Hong Kong, Macau, Singapore, South Korea
and Taiwan
Upfront and milestone payments of up to $86.6M
$21M in milestone payments largely under
Oncolytics’ control, with double-digit royalties
$65M tied to potential development expansion

wonder why?  is it a partnership or isn't it?  a partnership certainly has legal ramifications so wonder if there was some confidential change to the agreement.  there are certainly a number of confidential provisions in the agreement, maybe this was changed without notification.

seems odd.
Comment by TitanBrawler on Jan 11, 2023 10:29pm
Maybe we'll get a 50 billion dollar buyout next week Or next month or next year.. Just Keep buying more shares . LoL 
Comment by westcoast1000 on Jan 12, 2023 12:16am
Here is the key sentence: "Neither Party shall have any authority to bind the other in any way." In other words, they do not have linked, combined governance of some entity that can lead to commitments made by one party on behalf of the other party. A partnership could be defined in collquial, every day terms as an agreement to cooperate under the terms of the agreement. That is ...more  
Comment by itntdf on Jan 12, 2023 10:32am
yes, but a partnership does not "jointly pay taxes": A partnership must file an annual information return to report the income, deductions, gains, losses, etc., from its operations, but it does not pay income tax. Instead, it "passes through" profits or losses to its partners. Each partner reports their share of the partnership's income or loss. i just ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities